Journal article
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials
Abstract
Background: Guidelines recommend low-dose colchicine for secondary prevention in cardiovascular disease, but uncertainty remains concerning its efficacy for stroke, efficacy in key subgroups and about uncommon but serious safety outcomes.
Methods: In this trial-level meta-analysis, we searched bibliographic databases and trial registries form inception to May 16, 2024. We included randomised trials of colchicine for secondary prevention of …
Authors
Fiolet ATL; Poorthuis MHF; Opstal TSJ; Amarenco P; Boczar KE; Buysschaert I; Budgeon C; Chan NC; Cornel JH; Jolly SS
Journal
EClinicalMedicine, Vol. 76, ,
Publisher
Elsevier
Publication Date
10 2024
DOI
10.1016/j.eclinm.2024.102835
ISSN
2589-5370